Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Mylan launches generic Minastrin® 24 FE tablets in US

      Mylan launches generic Minastrin® 24 FE tablets in US

      Ruby Khatun Khatun18 Sept 2017 10:38 AM IST
      HERTFORDSHIRE, England, and PITTSBURGH: Mylan N.V. announced the U.S. launch of Norethindrone Acetate and Ethinyl Estradiol Tablets USP, and Ferrous...
      Zydus Nesher Pharma gets USFDA nod to market influenza drug

      Zydus Nesher Pharma gets USFDA nod to market influenza drug

      Ruby Khatun Khatun18 Sept 2017 10:28 AM IST
      New Delhi: Drug firm Zydus Cadila said Nesher Pharmaceuticals, a subsidiary of its US arm, has received final approval from the US health regulator to...
      GSK three-in-one inhaler gets positive opinion from EU agency

      GSK three-in-one inhaler gets positive opinion from EU agency

      Ruby Khatun Khatun18 Sept 2017 10:08 AM IST
      GlaxoSmithKline (GSK) said on Friday that a European Medicines Agency (EMA) panel has recommended the company’s three-in-one inhaled lung drug.GSK’s...
      Lilly, Incyte pill beats placebo in mid-stage eczema trial

      Lilly, Incyte pill beats placebo in mid-stage eczema trial

      Ruby Khatun Khatun18 Sept 2017 9:47 AM IST
      Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better...
      US senator slams Allergan patent deal with Native-American tribe

      US senator slams Allergan patent deal with Native-American tribe

      Ruby Khatun Khatun18 Sept 2017 9:31 AM IST
      US Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents “rips off consumers”...
      Tesaro ovarian cancer drug gets EU agency backing

      Tesaro ovarian cancer drug gets EU agency backing

      Ruby Khatun Khatun18 Sept 2017 9:15 AM IST
      A European Medicines Agency (EMA) panel recommended the approval of Tesaro Inc’s key drug, niraparib, for the treatment of recurrent ovarian...
      CDSCO declares certain blood grouping serums NOT OF STANDARD QUALITY

      CDSCO declares certain blood grouping serums NOT OF STANDARD QUALITY

      Ruby Khatun Khatun17 Sept 2017 11:58 AM IST
      New Delhi: Through a recent notification, Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health...
      India, Japan sign MoU for expansion of biotech lab

      India, Japan sign MoU for expansion of biotech lab

      Ruby Khatun Khatun17 Sept 2017 11:01 AM IST
      New Delhi: India and Japan signed a MoU for expansion of an international laboratory set up for a collaborative research in the area of...
      Zydus Cadila gets USFDA nod for two drugs

      Zydus Cadila gets USFDA nod for two drugs

      Ruby Khatun Khatun17 Sept 2017 10:24 AM IST
      New Delhi: Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator for its Modafinil and Solifenacin Succinate...
      Teva to sell womens health assets to CVC Capital Partners: report

      Teva to sell womens health assets to CVC Capital Partners: report

      Ruby Khatun Khatun17 Sept 2017 10:14 AM IST
      Teva Pharmaceutical Industries Ltd is close to a deal to sell its women’s health assets outside the United States to private equity firm CVC Capital...
      Astrazeneca Farxiga results may open up type 1 diabetes opportunity

      Astrazeneca Farxiga results may open up type 1 diabetes opportunity

      Ruby Khatun Khatun17 Sept 2017 9:57 AM IST
      FRANKFURT: AstraZeneca’s Farxiga was shown to help type-1 diabetics when added to standard insulin therapy, possibly opening up an additional market...
      Pfizer, Astellas prostate cancer drug promising in late-stage trial

      Pfizer, Astellas prostate cancer drug promising in late-stage trial

      Ruby Khatun Khatun17 Sept 2017 9:35 AM IST
      Pfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok